Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
106 words
Composition for inducing in vivo cartilage repair comprising an
osteoinductive and/or chondroinductive mixture of factors derived
from natural tissue or a sythetic mimic of such a mixture
encapsulated in nanospheres, whereby the nanospheres are polymer
particles having a size of less than 1000 nm and an in vitro
analytically determined release rate profile with an initial burst of 10
to 20% of the total load over the first 24 hours and a long time
release of at least 0.1 % per day during at least seven following days
and whereby the nanospheres are loaded with between 0.001 and
17% weight percent of the mixture of factors.
Claim 2
Dependent Claim
31 words
Composition according to claim 1, characterized in that the long term
release is between 0. 1 and 1 % of the total load per day over
between 40 and 70 days.
Claim 3
Dependent Claim
26 words
Composition according to claim 1 or 2, characterized in that the
osteoinductive and/or chondroinductive mixture of factors is derived
from bone, cartilage, tendon, meniscus or ligament.
Claim 4
Dependent Claim
33 words
Composition according to claim 1 or 2, characterized in that the
osteoinductive and/or chondroinductive mixture of factors is the
mixture known as BP (bone protein) derived from bovine long bones
and partly purified.
Claim 5
Dependent Claim
22 words
Composition according to claim 4, characterized , in that the nanospheres
are loaded with between 1 and 4% weight percent of BP.
Claim 6
Dependent Claim
35 words
Composition according to one of claims 1 to 5, characterized in that
the nanospheres consist of ((D,L)lactic acid / glycolic acid)copolymer
containing 20 to 80% of lactic acid and 80 to 20% of
glycolic acid.
Claim 7
Dependent Claim
28 words
Composition according to one of claims 1 to 5, characterized in that
the ((D,L)lactic acid / glycolic acid)-copolymer contains 50% of lactic
acid and 50% of glycolic acid.
Claim 8
Dependent Claim
19 words
Composition according to one of claims 1 to 7, characterized in that
the nanospheres are made by phase inversion.
Claim 9
Dependent Claim
19 words
Device containing the composition according to one of claims 1 to 8
and further comprising a porous biodegradable matrix.
Claim 10
Dependent Claim
18 words
Device according to claim 9, characterized in that it contains at least
2µg of loaded nanospheres per ml.
Claim 11
Dependent Claim
23 words
Device according to claim 9, characterized in that it contains at least
20ng of the osteoinductive and/or chondroinductive mixture of
factors per ml.
Claim 12
Dependent Claim
24 words
Device according to one of claims 9 to 11, characterized in that the
matrix has the form of a sponge, membrane, film or gel.
Claim 13
Dependent Claim
25 words
Device according to one of claims 9 to 12, characterized in that the
matrix consists of collagen type I, collagen type II or hyaluronic acid.
Claim 14
Dependent Claim
21 words
Use of the composition according to one of claims 1 to 8 for
preparing a device for in vivo cartilage repair.
Claim 15
Dependent Claim
16 words
Use according to claim 14, characterized in that the cartilage is
articular cartilage or meniscus cartilage.
Claim 16
Dependent Claim
22 words
Use of the composition according to one of claims 1 to 8 for cartilage
repair on an animal with a degenerative disease.
Claim 17
Dependent Claim
22 words
Use of the device according to one of claims 9 to 13 for cartilage
repair on an animal with a degenerative disease.
Claim 18
Dependent Claim
25 words
Method for in vivo cartilage repair comprising the step of filling a
cartilage defect with a device according to one of claims 9 to 13.
Claim 19
Dependent Claim
14 words
Method according to claim 18, characterized in that the defect is
dressed before filling.
Claim 20
Dependent Claim
25 words
Method for in vitro cartilage repair comprising the step of applying to
the cartilage defect a composition according to one of claims 1 to 8.
Claim 21
Dependent Claim
14 words
Method according to claim 20, characterized in that the composition
is applied by injection.
Claim 22
Dependent Claim
25 words
Method according to claim 20 or 21, characterized in that the
composition is applied in an amount of at least 2µg per ml defect
size.
Claim 23
Dependent Claim
40 words
Method according to claim 20 or 21, characterized in that the
composition is applied in an amount such that the osteoinductive
and/or chondroinductive mixture is present in the defect in an
amount of at least 20ng per ml defect size.